Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

71.80 -0.44 (-0.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,383,044
Open 72.10
Bid (Size) 71.79 (43)
Ask (Size) 71.80 (4)
Prev. Close 72.24
Today's Range 71.09 - 72.56
52wk Range 62.34 - 142.00
Shares Outstanding 390,600,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why DexCom Stock Flopped on Friday
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth. 
Via The Motley Fool
Analyst Expectations For DexCom's Future
Via Benzinga

Performance

YTD
-41.67%
-41.67%
1 Month
+7.10%
+7.10%
3 Month
+3.01%
+3.01%
6 Month
-43.64%
-43.64%
1 Year
-15.44%
-15.44%

More News

Read More
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
Via Benzinga
Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
Via Talk Markets
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
Via Investor's Business Daily
Where Will DexCom Be in 5 Years?
Via The Motley Fool
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Via Benzinga
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
DexCom (DXCM) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DexCom Stock Drops After Q3 Results, Announces C-Suite Transition
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash.
Via Investor's Business Daily
Dexcom Reports Third Quarter 2024 Financial Results
From DexCom, Inc.
Via Business Wire
Tech Stocks Rebound, Tesla Soars To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Via Benzinga
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tech Stocks Rebound With Tesla Soaring To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Via Benzinga
Jim Cramer Calls AST SpaceMobile 'Overvalued,' Warns HubSpot Is 'Playing With Fire'
Via Benzinga
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi, LLP
Via Business Wire
RLF Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
From The Law Offices of Frank R. Cruz
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
DXCM Deadline in 7 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.